U.S. Markets open in 40 mins
  • Gold

    1,803.40
    +4.60 (+0.26%)
     
  • EUR/USD

    1.1627
    +0.0020 (+0.1744%)
     
  • 10-Yr Bond

    1.5400
    +0.0110 (+0.72%)
     
  • Vix

    16.64
    +0.66 (+4.13%)
     
  • GBP/USD

    1.3752
    +0.0010 (+0.0715%)
     
  • USD/JPY

    113.6500
    -0.1600 (-0.1406%)
     
  • BTC-USD

    61,131.63
    +2,365.86 (+4.03%)
     
  • CMC Crypto 200

    1,475.01
    +0.68 (+0.05%)
     
  • FTSE 100

    7,235.42
    -17.85 (-0.25%)
     
  • Nikkei 225

    28,820.09
    -278.11 (-0.96%)
     

Why Sarepta Therapeutics Tumbled Today

·2 min read
Why Sarepta Therapeutics Tumbled Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

On the back of two pieces of news released after market hours on Tuesday, Sarepta Therapeutics (NASDAQ: SRPT) stock fell by over 12% today. Investors were displeased with a company update about its fundamentals, and a new share issue. In separate press releases, Sarepta gave investors a glimpse of its upcoming third-quarter earnings release, and provided details of that share issue.